Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Beginning Cash Balance Beginning Cash Balance Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Cost of Revenue Gross Profit Long-Term Debt Issuances Long-Term Debt Repayments Preferred Shares Issued Receivables - Net Receivables - Other Revenue - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances Wages, Salaries and Other

Creative Medical Technology Holdings (CELZ) Short-Term Debt repayments (2019)

Creative Medical Technology Holdings has reported Short-Term Debt repayments over the past 2 years, most recently at $100000.0 for Q4 2019.

Quarterly Short-Term Debt repayments changed N/A to $100000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Dec 2020, changed 0.0% year-over-year, with the annual reading at $50000.0 for FY2019, N/A changed from the prior year.
Short-Term Debt repayments was $100000.0 for Q4 2019 at Creative Medical Technology Holdings, up from -$3000.0 in the prior quarter.
Over five years, Short-Term Debt repayments peaked at $100000.0 in Q4 2019 and troughed at -$3000.0 in Q1 2015.